Securities code: 002755 securities abbreviation: Beijing Aosaikang Pharmaceutical Co.Ltd(002755) Announcement No.: 2022-022 Beijing Aosaikang Pharmaceutical Co.Ltd(002755)
Independent opinions of independent directors on matters related to the first meeting of the sixth board of directors of the company
In accordance with the guidelines for self-regulation of listed companies of Shenzhen Stock Exchange No. 1 – Guidelines for the standardized operation of listed companies on the main board, the guidelines for the governance of listed companies, the articles of association and the working system of independent directors and other relevant provisions, as independent directors of the company, we have checked the relevant materials with a serious, responsible and independent judgment attitude, and after careful analysis, We hereby express the following independent opinions on matters related to the appointment of senior managers at the first meeting of the sixth board of directors of the company: After reviewing the personal resumes of Mr. Ma Jingfei, Mr. Xu Youyin, Mr. Zhang Jianyi and Mr. Han Tao, we believe that the above personnel meet the requirements of the company law and the articles of association on the qualification of senior managers of listed companies, There are no circumstances stipulated in Article 146 of the company law, no punishment by the CSRC and other relevant departments and the punishment of the stock exchange, and no other circumstances that may not serve as senior managers of listed companies. It is understood that his educational background, work experience and physical condition can meet the responsibilities of the corresponding positions of the company, which is conducive to the development of the company. The nomination, appointment and voting procedures of the company’s senior managers comply with relevant laws, regulations and the articles of association.
The appointment of senior managers will not lead to the total number of directors who concurrently serve as senior managers of the company and staff representatives in the board of directors of the company exceeding half of the total number of directors of the company.
Mr. Ma Jingfei has obtained the qualification certificate of secretary of the board of directors issued by Shenzhen Stock Exchange, and his qualification has been reviewed by Shenzhen stock exchange without objection.
To sum up, we agree that the company appoints Mr. Ma Jingfei as the general manager and Secretary of the board of directors, Mr. Xu Youyin and Mr. Zhang Jianyi as the deputy general manager and Mr. Han Tao as the chief financial officer of the company.
(there is no text below, which is the signature page)
(there is no text on this page, which is the signature page of Beijing Aosaikang Pharmaceutical Co.Ltd(002755) independent directors’ independent opinions on matters related to the first meeting of the sixth board of directors of the company) independent directors:
Wu Xiaoming, Li Di, Liu Jianwen
February 18, 2022
